retatrutide fda approval date Letter regarding Retatrutide's TRIUMPH-1 result explains why

Retatrutide, in this new class of drugs, could provide doctors with additional tools to assist

Some patients may use customized options known as compounded GLP-1 medications

Studies have found it associated with significant weight loss when taken regularly by overweight or obese individuals, who attempted an exercise program to shave excess pounds for over two years

***Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program

doi: 10.1002/ptr.2187, 98

As such, addressing these areas is a good place to start